ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979

Obey Attacks NCI, Eppley, Shubick, Asks for Full Report From GAO

June 10, 1977

Eight Win ASCO Young Investigator Awards

August 22, 1986

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Intramural Clinical Research Could Lose “Critical Mass” – Chabner

November 11, 1994

In Brief: Kovac, Bunn Lead AACI; Hollings Researcher Wins Immunology Award; Turrisi Moves To SC

September 16, 1994